Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Biometrical Journal. Biometrische Zeitschrift|October 5, 2010
Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpointS Krishna Padmanabhan, Vladimir DragalinJournal of Biopharmaceutical Statistics|November 21, 2007
Adaptive designs for dose-finding studies based on sigmoid Emax modelVladimir Dragalin, Francis Hsuan, S Krishna PadmanabhanJournal of Biopharmaceutical Statistics|January 19, 2012
A bayesian dose-finding design adapting to efficacy and tolerability responseS Krishna Padmanabhan, Scott Berry, Vladimir Dragalin, et al.Journal of Clinical Psychopharmacology|July 16, 2010
Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxineKaren A Tourian, Krishna Padmanabhan, Jim Groark, et al.International Clinical Psychopharmacology|June 4, 2005
Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placeboCharles Shelton, Richard Entsuah, S Krishna Padmanabhan, et al.Alimentary Pharmacology & Therapeutics|July 29, 2026
Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 SubsetMaria Mironova, Krishna Padmanabhan, David Schneider, et al.The Primary Care Companion for CNS Disorders|October 7, 2011
A 10-month, open-label evaluation of desvenlafaxine in outpatients with major depressive disorderKaren A Tourian, Bruno Pitrosky, S Krishna Padmanabhan, et al.CNS Spectrums|January 27, 2009
A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorderAlan D Feiger, Karen A Tourian, Gregory R Rosas, et al.Clinical Therapeutics|August 25, 2009
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studiesKaren A Tourian, S Krishna Padmanabhan, James Groark, et al.International Clinical Psychopharmacology|October 6, 2007
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorderLucia Septien-Velez, Bruno Pitrosky, Sudharshan Krishna Padmanabhan, et al.Pageof 2